TP53 and sarcoma: In fact, the only detectable variations ascribable to the lack of immune surveillance were the slightly faster onset of tumors, in particular sarcomas, in RGKO-p53+/− mice and the slower growth of tumor cells derived from the same tumors in immunocompetent versus immunodeficient hosts.